查詢結果分析
來源資料
相關文獻
- Drug Resistance of Mycobacterium Tuberculosis in Eastern Taiwan
- Drug Resistance Patterns of Tuberculosis in Taiwan
- 偵測多種抗藥性結核桿菌的最新發展
- Clinical Analysis of Mycobacterium Tuberculosis Infection in Patients with Acquired Immunodeficiency Syndrome
- Determination of the Sensitivity and Specificity of PCR Assays Using Different Target DNAs for the Detection of Mycobacterium Tuberculosis
- 結核桿菌於Bactec Radiometric System及Lowenstein-Jensen Medium生長測定之比較及抗結核藥物感受性之研究
- Demonstration of the Mycobacterium tuberculosis Complex Strain in Urine from a Patient with Suspected Urinary Tract Tuberculosis
- Detection of Mycobacterium Tuberculosis by Nested PCR and Histological Analysis in Formalin-Fixed Paraffin-Embedded Tissue
- 痰液中肺結核桿菌的偵測與藥敏試驗
- Mycobacterium Chelonei Tenosynovitis of the Hand: A Case Report and Literature Review
頁籤選單縮合
題 名 | Drug Resistance of Mycobacterium Tuberculosis in Eastern Taiwan=臺灣東部地區結核菌抗藥性現況 |
---|---|
作 者 | 李仁智; 李俊年; 索任; 姜義新; 林智斌; 林等義; 蔡永川; | 書刊名 | 慈濟醫學 |
卷 期 | 15:4 2003.08[民92.08] |
頁 次 | 頁229-234 |
分類號 | 415.2773 |
關鍵詞 | 結核桿菌; 原發性抗藥; 獲得性抗藥; Mycobacterium tuberculosis; Primary drug resistance; Acquired drug resistance; |
語 文 | 英文(English) |
中文摘要 | 目的:評估臺灣東部地區結核菌的抗藥性現況。材料與方法:西元2001年1月到2002年12月間在慈濟醫院培養出的結核桿菌菌株有252例使用比例法完成藥物感受性試驗。結果:72株(28.6%)有抗藥性問題,各個藥物的綜合性抗藥比例分別為isoniazid, 21.8%;streptomycin, 8.3%,rifampin, 12.7%和ethambutol, 12.7%。190例末治療過病人的菌株中16.8%有抗藥性。原發性抗藥比例分別為isoniazid, 11.0%;ethambutol, 5.8%;streptomycin, 5.3%和rifampin, 2.1%。原發多重抗藥比例為2.1%。62例曾治療過患者的菌株中64.5%有抗藥性。獲得性抗藥比例分別為isoniazid, 54.8%;streptomycin, 17.7%;rifampin, 45.2%和ethambutol, 33.9%。結論:臺灣東部地區的抗藥性比例非常地高,應當定期地在東部監測抗藥性的變化。應採取適當措施例如直接監督治療來保護rifampin以減少多重藥物抗藥性。 |
英文摘要 | Objective: To evaluate patterns of drug resistance of Mycobacterium tuberculosis in eastern Taiwan. Materials and Methods: Two hundred and fifty-two isolates collected from January 2001 through December 2002 were tested for drug susceptibility using the agar proportion method at Tzu Chi General Hospital. Results: The overall rate of resistance to at least one drug was 28.6%. The overall resistance rates to individual drugs were 21.8% to isoniazid, 8.3% to streptomycin, 12.7% to rifampin, and 12.7% to ethambutol. Among the 190 isolates from patients without prior treatment, 16.8% of the strains were resistant to at least one drug. Resistance to isoniazid(11.1%), ethambutol(5.8%), or streptomycin(5.3%) was more common than resistance to rifampin (2.1%). The prevalence of primary multidrug resistance was 2.1%. Among the 62 isolates from patients with histories of anti-TB treatment, the prevalence of resistance to any of the four drugs was 64.5%. The acquired resistance rates to individual drugs were 54.8% to isoniazid, 17.7% to streptomycin, 45.2% to rifampin, and 33.9% to ethambutol. Conclusions: The prevalence of drug resistance is very high in eastern Taiwan, and the surveys for anti-tuberculosis drug resistance should be repeated annually. Measures to decrease the multidrug-resistance rate are greatly needed. |
本系統中英文摘要資訊取自各篇刊載內容。